FDA inspection
Unexo Life Sciences Private Limited: FDA inspection ending May 14, 2024
FDA inspection 1239138 · Official Action Indicated (OAI) · New Delhi
Key facts
| Inspection ID | 1239138 |
|---|---|
| Firm | Unexo Life Sciences Private Limited |
| FEI number | 3013514280 |
| Address | B16, Sector 4, Bawana Industrial Area |
| City | New Delhi |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | May 14, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 688163 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data